Otsuka Holdings Co., Ltd. (FRA:OS1)
Germany flag Germany · Delayed Price · Currency is EUR
57.50
+0.50 (0.88%)
At close: Feb 20, 2026

Revenue by Geography

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Japan Revenue
718.10B699.70B
Japan Revenue Growth
2.63%4.29%
North America Revenue
1.17T1.10T
North America Revenue Growth
6.74%25.38%
Europe Revenue
284.90B242.90B
Europe Revenue Growth
17.29%11.06%
Others Revenue
297.00B292.20B
Others Revenue Growth
1.64%14.27%
Overseas Revenue
1.75T1.63T
Overseas Revenue Growth
7.40%20.96%

Revenue

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Revenue
1.74T1.63T
Pharmaceuticals Revenue Growth
7.07%17.10%
Nutraceuticals Revenue
577.62B557.01B
Nutraceuticals Revenue Growth
3.70%15.25%
Consumer Products Revenue
34.61B33.75B
Consumer Products Revenue Growth
2.54%-8.94%
Other Segment Revenue
112.43B110.07B
Other Segment Revenue Growth
2.14%2.85%

Adjusted EBIT

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Business Profit
402.02B390.61B
Pharmaceuticals Business Profit Growth
2.92%38.47%
Nutraceuticals Business Profit
68.91B64.15B
Nutraceuticals Business Profit Growth
7.42%6.09%
Consumer Products Business Profit
25.17B23.66B
Consumer Products Business Profit Growth
6.38%30.72%
Other Segment Business Profit
7.47B6.95B
Other Segment Business Profit Growth
7.44%121.83%
Eliminations from Business Profit
-57.43B-54.91B

EBIT

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Mar '14 Mar '13
Pharmaceuticals Segment Profit
445.30B285.11B
Pharmaceuticals Segment Profit Growth
56.19%98.47%
Nutraceuticals Segment Profit
57.72B59.78B
Nutraceuticals Segment Profit Growth
-3.44%74.56%
Consumer Products Segment Profit
25.15B23.00B
Consumer Products Segment Profit Growth
9.36%89.50%
Other Segment Profit
7.98B7.53B
Other Segment Profit Growth
6.10%2606.84%
Eliminations from Segment Profit
-56.78B-51.85B
Updated Dec 31, 2025. Data Source: Fiscal.ai.